Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Juliusson

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Cancer|August 1, 1986
Immunologic and cytogenetic studies improve prognosis prediction in chronic B-lymphocytic leukemia. A multivariate analysis of 24 variablesG Juliusson
Drugs|January 1, 1994
Immunological and genetic abnormalities in chronic lymphocytic leukaemia. Impact of the purine analoguesG Juliusson
Hematology and Cell Therapy|February 21, 1998
Complications in the treatment of CLL with purine analoguesG Juliusson
Cancer Research|October 15, 1991
On the pharmacokinetics of 2-chloro-2'-deoxyadenosine in humansJ Liliemark, G Juliusson
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Clinical implication of chromosomal aberrations in chronic B-lymphocytic leukaemia cellsG Gahrton, G Juliusson
Cancer Genetics and Cytogenetics|December 1, 1985
Abnormal/normal metaphase ratio and prognosis in chronic B-lymphocytic leukemiaG Juliusson, G Gahrton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte countG Juliusson, J Liliemark
Leukemia & Lymphoma|March 1, 1994
Retreatment of chronic lymphocytic leukemia with 2-chlorodeoxyadenosine (CdA) at relapse following CdA-induced remission: no acquired resistanceG Juliusson, J Liliemark
Seminars in Oncology|March 3, 1998
Cytogenetics in chronic lymphocytic leukemiaG Juliusson, M Merup
Cancer Genetics and Cytogenetics|April 1, 1990
Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implicationsG Juliusson, G Gahrton
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Cancer|August 1, 1986
Immunologic and cytogenetic studies improve prognosis prediction in chronic B-lymphocytic leukemia. A multivariate analysis of 24 variablesG Juliusson
Drugs|January 1, 1994
Immunological and genetic abnormalities in chronic lymphocytic leukaemia. Impact of the purine analoguesG Juliusson
Hematology and Cell Therapy|February 21, 1998
Complications in the treatment of CLL with purine analoguesG Juliusson
Cancer Research|October 15, 1991
On the pharmacokinetics of 2-chloro-2'-deoxyadenosine in humansJ Liliemark, G Juliusson
Nouvelle Revue Francaise D'Hematologie|January 1, 1988
Clinical implication of chromosomal aberrations in chronic B-lymphocytic leukaemia cellsG Gahrton, G Juliusson
Cancer Genetics and Cytogenetics|December 1, 1985
Abnormal/normal metaphase ratio and prognosis in chronic B-lymphocytic leukemiaG Juliusson, G Gahrton
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte countG Juliusson, J Liliemark
Leukemia & Lymphoma|March 1, 1994
Retreatment of chronic lymphocytic leukemia with 2-chlorodeoxyadenosine (CdA) at relapse following CdA-induced remission: no acquired resistanceG Juliusson, J Liliemark
Seminars in Oncology|March 3, 1998
Cytogenetics in chronic lymphocytic leukemiaG Juliusson, M Merup
Cancer Genetics and Cytogenetics|April 1, 1990
Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implicationsG Juliusson, G Gahrton
Pageof 12